|Bid||0.00000 x 0|
|Ask||0.00000 x 0|
|Day's Range||1.22350 - 1.30000|
|52 Week Range||0.67000 - 2.95000|
|Beta (3Y Monthly)||1.86|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace provides the following statement related to the legalization of marijuana for recreational use across Canada: “The introduction of legalized marijuana use in Canada is a watershed moment as it relates to public safety on our roads and workplaces.
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that characterization work has demonstrated the ability to isolate ∆9-tetrahydrocannabinol (“THC”) and suppress background substrates effectively. Cannabix is developing an innovative FAIMS (field asymmetric waveform ion mobility spectrometry) based instrument for the detection of THC. Using the gold standard of mass spectrometry in tandem with the Cannabix FAIMS prototype device, Graph A and B below show suppression of background matrix allowing the THC peak to be easily recognized. This demonstrates the capability of the FAIMS device to isolate and detect THC from complex background matrix.